Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma

Abroad (travel likely)Recruiting

Conditions

Advanced Hepatocellular Carcinoma · Chemotherapy · Stereotactic Body Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Yongin Severance Hospital, Yongin-si, South Korea
Contact: Study coordinator (Hwakyung BYUN, Phd) · hkbyun05@yuhs.ac · 0079803151898166

Study leads

Hwakyung BYUN, Phd
Principal Investigator
Severance Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Metastatic Hepatocellular Carcinoma · Local Advanced Hepatocellular Carcinoma · Alpha-fetoprotein (AFP)-Producing Gastric Cancer

Abroad (travel likely)RecruitingPHASE1

Goodyear, United States · Duarte, United States

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma (HCC)

Abroad (travel likely)RecruitingPHASE2

Lanzhou, China · Guangzhou, China

A Study of BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1

San Diego, United States